Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Rowan Companies PLC (NYSE:RDC)?

Rowan Companies PLC (NYSE:RDC) has experienced a decrease in activity from the world’s largest hedge funds in recent months.

In the 21st century investor’s toolkit, there are plenty of methods investors can use to watch publicly traded companies. Two of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite hedge fund managers can trounce the broader indices by a healthy margin (see just how much).

Rowan Companies PLC (NYSE:RDC)

Equally as important, optimistic insider trading sentiment is another way to parse down the stock market universe. There are many stimuli for a bullish insider to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Various academic studies have demonstrated the useful potential of this strategy if you understand what to do (learn more here).

Keeping this in mind, we’re going to take a glance at the latest action encompassing Rowan Companies PLC (NYSE:RDC).

Hedge fund activity in Rowan Companies PLC (NYSE:RDC)

In preparation for this year, a total of 20 of the hedge funds we track were bullish in this stock, a change of 0% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were increasing their stakes substantially.

Of the funds we track, Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, holds the largest position in Rowan Companies PLC (NYSE:RDC). Arrowstreet Capital has a $228 million position in the stock, comprising 1.2% of its 13F portfolio. On Arrowstreet Capital’s heels is QVT Financial, managed by Daniel Gold, which held a $35 million position; 1.2% of its 13F portfolio is allocated to the company. Remaining peers with similar optimism include Ken Griffin’s Citadel Investment Group, Mario Gabelli’s GAMCO Investors and Steven Cohen’s SAC Capital Advisors.

Due to the fact that Rowan Companies PLC (NYSE:RDC) has experienced declining sentiment from the aggregate hedge fund industry, it’s easy to see that there was a specific group of fund managers that slashed their full holdings in Q4. It’s worth mentioning that Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC dumped the biggest stake of the “upper crust” of funds we track, totaling close to $237 million in stock.. Phill Gross and Robert Atchinson’s fund, Adage Capital Management, also sold off its stock, about $8 million worth. These moves are interesting, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Rowan Companies PLC (NYSE:RDC)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company in question has experienced transactions within the past 180 days. Over the last 180-day time frame, Rowan Companies PLC (NYSE:RDC) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

With the results exhibited by Insider Monkey’s strategies, everyday investors should always watch hedge fund and insider trading sentiment, and Rowan Companies PLC (NYSE:RDC) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!